Adagene Inc.
ADAG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818838
In the last 90 days, Adagene Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $81.0M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Adagene Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 14 | 13 | −1 |
| Shares | 11.2M | 11.2M | −65.7K (−0.6%) |
| Value | $33.7M | $25.3M | −$8.39M (−24.9%) |
New holders (1)
Institutions that held Adagene Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mill Creek Capital Advisors, LLC | 90,908 | $201.8K | 0.00% |
Sold out (2)
Institutions that held Adagene Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| UBS Group AG | 164 | $502 |
| Qube Research & Technologies Ltd | 47 | $144 |